Utah Medical Products, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Kevin L. Cornwell
- Full Time Employees
- 146
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 7043 South 300 West Midvale UT United States of America 84047-1048
- IPO Date
- Mar 8, 1999
- CIK
- 0000706698
- Website
- utahmed.com
- Similar Companies
- Business
- Utah Medical Products, Inc. develops, manufactures, and distributes proprietary medical devices primarily for labor and delivery, neonatal intensive care, women's health, urology, surgery, and critical care. Its core product portfolio includes fetal monitoring accessories; vacuum-assisted delivery systems; labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; DELTRAN PLUS blood pressure monitoring systems; Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization products; LIBERTY urinary incontinence treatment systems; ENDOCURETTE uterine endometrial tissue sampling curettes; and LUMIN uterine manipulation tools for laparoscopic procedures. The company targets hospitals, outpatient clinics, and physicians' offices globally. Founded in 1975 and headquartered in Salt Lake City, Utah, Utah Medical Products maintains a strong presence in the US medical device market and select international markets. In the last two years, the company has focused on strengthening its financial position amid sales fluctuations, notably reduced sales to a key OEM partner PendoTECH, while continuing to expand its product offerings with new devices like the CVX-Ripe cervical ripening catheter introduced to improve labor induction outcomes. Utah Medical Products also increased its quarterly dividend and appointed a new director in late 2024 and early 2025, reflecting a commitment to shareholder value and governance enhancements. It benefits from strong institutional ownership and has sustained share repurchase programs despite challenges from trade disruptions and rising operational costs.
Company News
UTMD Trades at a Premium to the Industry: How to Play the Stock?
Utah Medical Products, Inc. Extends Tender Offer
Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
Utah Medical Products, Inc. Commences Tender Offer
UTMD Announces Self-Tender for 20% of Its Shares
BlackRock Inc. Invests $14.05 Million in Utah Medical Products, Inc. $UTMD
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
Head-To-Head Comparison: Utah Medical Products (NASDAQ:UTMD) and INLIF (NASDAQ:INLF)
Utah Medical Gains 32% in a Year: Should You Buy the Stock?
The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products
Utah Medical Products (NASDAQ:UTMD) Stock Passes Above 200 Day Moving Average – Here’s What Happened
Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y
Utah Medical Products, Inc. Announces Quarterly Dividend
UTMD Reports Year 2025 and Fourth Quarter Financial Performance